02.02.2013 Views

(Cr) Toxicity | ATSDR - CSEM - Agency for Toxic Substances and ...

(Cr) Toxicity | ATSDR - CSEM - Agency for Toxic Substances and ...

(Cr) Toxicity | ATSDR - CSEM - Agency for Toxic Substances and ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

<strong>Agency</strong> <strong>for</strong> <strong>Toxic</strong> <strong>Substances</strong> <strong>and</strong> Disease Registry Chromium <strong><strong>Toxic</strong>ity</strong><br />

Case Studies in Environmental Medicine (<strong>CSEM</strong>)<br />

Key Points • No proven antidote is available <strong>for</strong> chromium poisoning.<br />

• Treatment in cases of acute high-level chromium exposure is usually<br />

supportive <strong>and</strong> symptomatic.<br />

• Treatment consists of removal of the patient from further chromium<br />

exposure, reliance on the body’s naturally rapid clearance of the metal<br />

<strong>and</strong> symptomatic management.<br />

• The physician can provide advice <strong>and</strong> patient education regarding<br />

smoking cessation, how to avoid or minimize exposure to other known<br />

pulmonary carcinogens, <strong>and</strong> general preventive health measures.<br />

Progress Check<br />

13. Which of following measures is incorrect when managing patients with<br />

acute chromium poisoning:<br />

A. Ventilatory <strong>and</strong> cardiovascular support.<br />

B. Maintenance of adequate urine.<br />

C. Induction of vomiting.<br />

D. Hepatic function monitoring.<br />

To review relevant content, see “Acute Exposure” in this section.<br />

14. Which of the following statements is incorrect?<br />

A. Except in the lungs, only small amounts of chromium are retained<br />

several weeks after exposure has ceased.<br />

B. Dermatitis, liver, <strong>and</strong> renal injury will not progress after removal from<br />

exposure.<br />

C. If the exposure has been lengthy (i.e., 2 years to 3 years), the<br />

increased risk of lung cancer should be discussed with the patient.<br />

D. The mainstay of management <strong>for</strong> chronic exposure is relying on<br />

chromium clearance techniques, such as hemodialysis, exchange<br />

transfusions, or chelating agents such as dimercaprol or EDTA.<br />

To review relevant content, see “Chronic Exposure” in this section.<br />

Page 49 of 67

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!